Dexcom Announces Upcoming Conference Presentation

SAN DIEGO--(BUSINESS WIRE)-- DexCom, Inc. (NASDAQ: DXCM) today announced that management will present an update on the company at the 47th Annual Raymond James Institutional Investors Conference on Monday, March 2, 2026.

The live presentation is scheduled to begin at approximately 1:05 PM EST and will be concurrently webcast.

Links to the webcast will be available on the Dexcom Investor Relations website at investors.dexcom.com and will be archived there for future reference.

About DexCom, Inc.

Dexcom empowers people to take control of health through innovative biosensing technology. Founded in 1999, Dexcom has pioneered and set the standard in glucose biosensing for more than 25 years. Its technology has transformed how people manage diabetes and track their glucose, helping them feel more in control and live more confidently.

Dexcom. Discover what you’re made of. For more information, visit www.dexcom.com.

Category: IR

View source version on businesswire.com: https://www.businesswire.com/news/home/20260225371506/en/

DexCom, Inc.
Sean Christensen
Vice President – Finance and Investor Relations
[email protected]
(858) 200-0200

Source: DexCom, Inc.

You May Also Be Interested In

• DexCom (DXCM) PT Raised to $85 at Mizuho
• GCL SI Showcases Scenario-Based PV Solutions at SNEC 2026, Driving Application-Specific Solar Deployment and Low-Carbon Development
• U.S. Federal Court Dismisses Natsoft's Patent Claims Against Hexaware